Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS, et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 2000 Jun;18(12):2444-58 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/10856105.
Compare quality appraisals for each clinical question
- What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?